Taub Rebecca 4

What Happened

• Rebecca Taub, a director of Madrigal Pharmaceuticals (MDGL), had 647 shares sold on 2026-01-26 at $492.42 per share, generating $318,596. The sale was executed to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs).

Key Details

• Transaction date and price: 2026-01-26, 647 shares at $492.42 each.
• Total proceeds: $318,596 (gross).
• Shares owned after the transaction: Not specified in the filing.
• Footnotes: The sale was automatic and executed by the issuer on behalf of the reporting person to satisfy tax withholding (sell-to-cover). The reporting person and her spouse are managing members of SQN, LLC; she disclaims beneficial ownership of securities held by SQN except to the extent of any pecuniary interest.
• Filing timeliness: Reported on 2026-01-26 (same day as the transaction), indicating a timely Form 4 filing.

Context

• This was a routine sell-to-cover tied to RSU vesting rather than an opportunistic open-market trade; such automatic sales are commonly used solely to satisfy tax withholding and do not necessarily signal the insider’s view on the company.